No connection

Search Results

KEQU vs TSLA

KEQU
Kewaunee Scientific Corporation
BEARISH
Price
$34.92
Market Cap
$100.1M
Sector
Consumer Cyclical
AI Confidence
85%
TSLA
Tesla, Inc.
BEARISH
Price
$343.25
Market Cap
$1.29T
Sector
Consumer Cyclical
AI Confidence
95%

Valuation

P/E Ratio
KEQU
9.39
TSLA
323.82
Forward P/E
KEQU
16.17
TSLA
122.13
P/B Ratio
KEQU
1.42
TSLA
15.68
P/S Ratio
KEQU
0.35
TSLA
13.58
EV/EBITDA
KEQU
5.89
TSLA
119.91

Profitability

Gross Margin
KEQU
28.93%
TSLA
18.03%
Operating Margin
KEQU
3.72%
TSLA
4.7%
Profit Margin
KEQU
3.85%
TSLA
4.0%
ROE
KEQU
17.41%
TSLA
4.92%
ROA
KEQU
6.85%
TSLA
2.1%

Growth

Revenue Growth
KEQU
3.3%
TSLA
-3.1%
Earnings Growth
KEQU
-48.9%
TSLA
-60.6%

Financial Health

Debt/Equity
KEQU
0.82
TSLA
0.18
Current Ratio
KEQU
2.12
TSLA
2.16
Quick Ratio
KEQU
1.28
TSLA
1.54

Dividends

Dividend Yield
KEQU
--
TSLA
--
Payout Ratio
KEQU
0.0%
TSLA
0.0%

AI Verdict

KEQU BEARISH

KEQU presents a contradictory profile where a stable Piotroski F-Score (4/9) is overshadowed by a severe collapse in earnings growth (-48.90% YoY) and a dismal earnings track record (0/3 beats). While the current price of $34.92 sits below the Graham Number ($45.43), it trades at a premium to its growth-based intrinsic value of $26.04. The combination of a 0/100 technical trend and aggressive insider selling by both the CEO and CFO suggests a lack of confidence in near-term recovery. Despite a low trailing P/E, the rising forward P/E indicates that the market expects further earnings deterioration.

Strengths
Low trailing P/E (9.39) relative to sector average (37.71)
Strong Return on Equity (ROE) of 17.41%
Healthy liquidity with a Current Ratio of 2.12
Risks
Severe earnings contraction (-48.90% YoY)
Consistent failure to meet earnings estimates (0/3 beats, -82.16% avg surprise)
Bearish insider sentiment with CEO and CFO selling shares
TSLA BEARISH

Tesla's deterministic health is stable with a Piotroski F-Score of 4/9, but its valuation is fundamentally disconnected from current performance. The Graham Number ($22.85) and Intrinsic Value ($7.42) indicate extreme overvaluation relative to the current price of $343.25. With negative YoY revenue growth (-3.10%) and a collapse in earnings growth (-60.60%), the P/E ratio of 323.82 is unsustainable. Technical trends and insider activity are both strongly bearish, suggesting a significant correction is likely.

Strengths
Very low Debt/Equity ratio (0.18) indicating minimal leverage risk
Strong liquidity with a Current Ratio of 2.16 and Quick Ratio of 1.54
Dominant market capitalization and sector leadership
Risks
Extreme valuation multiples (P/E 323.82, PEG 4.92) far exceeding peer averages
Severe earnings contraction with YoY Earnings Growth at -60.60%
Negative revenue growth (-3.10%) signaling a potential peak in market penetration

Compare Another Pair

KEQU vs TSLA: Head-to-Head Comparison

This page compares Kewaunee Scientific Corporation (KEQU) and Tesla, Inc. (TSLA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile